Binding of psychotropic drugs to isolated alpha-acid glycoprotein.
Alpha1-acid glycoprotein (alpha1-AG) was purified from human sera, and its binding properties with respect to psychotropic drugs were examined by equilibrium dialysis methods in order to clarify the specificity of binding. Radioactive imipramine, a tricyclic antidepressant, was used as the primary ligand. Other drugs, representative of different classes, were tested as potential inhibitors of the alpha1-AG-imipramine binding. The K(a) for imipramine was 2.8 x 10(5) (+/- 0.8) M(-10 (mean +/- S.D.). Chlorpromazine, fluphenazine, thioridazine, loxapine and thiothixene, which are antipsychotic drugs, were competitive inhibitors of imipramine binding, and their K(a) values were in the same range. Propranolol, haloperidol and diazepam were also competitive inhibitors but their affinities were lower. Molindone, an indolic antipsychotic, when tested at the same concentrations as the other drugs, did not affect imipramine binding. Trihexyphenidyl, an anti-Parkinson drug, was a potent but noncompetitive inhibitor. These data identify the antidepressant and major tranquilizer drugs that exhibit high affinity for alpha1-AG and indicate that alpha1-AG may account for 40 per cent of total imipramine bound in serum. Since in psychiatric clinical practice two drugs are frequently administered together, possible competitive effects are discussed as well as the potential role of alpha1-AG in psychiatric illness.
Department of Psychiatry, Psychiatric Institute, Clinical Sciences Center, University of Wisconsin, Madison, WI 53792, USA.
M L
ML
Kornguth
L G
LG
Hutchins
B S
BS
Eichelman
D001667:Binding, Competitive / Q000187:drug effects; D002746:Chlorpromazine / Q000378:metabolism / Q000494:pharmacology; D005476:Fluphenazine / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D007099:Imipramine / Q000378:metabolism* / Q000494:pharmacology; D007700:Kinetics; D008152:Loxapine / Q000378:metabolism / Q000494:pharmacology; D008972:Molindone / Q000378:metabolism / Q000494:pharmacology; D009961:Orosomucoid / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects; D011619:Psychotropic Drugs / Q000145:classification / Q000378:metabolism* / Q000494:pharmacology; D013881:Thioridazine / Q000378:metabolism / Q000494:pharmacology; D013888:Thiothixene / Q000378:metabolism / Q000494:pharmacology; D014282:Trihexyphenidyl / Q000378:metabolism / Q000494:pharmacology
D009961:Orosomucoid; D011619:Psychotropic Drugs; D014282:Trihexyphenidyl; D013888:Thiothixene; D008152:Loxapine; D013881:Thioridazine; D007099:Imipramine; D008972:Molindone; D005476:Fluphenazine; D002746:Chlorpromazine